[Blood viscosity. Measurement and applications (hyper--and hypoviscosity syndromes) (author's transl)]
- PMID: 7232152
[Blood viscosity. Measurement and applications (hyper--and hypoviscosity syndromes) (author's transl)]
Abstract
Blood has particular rheological properties which partly condition its flow, especially in capillary vessels, and its ability to deliver oxygen. It is not subject to gravitation, pseudoplastic, thixotropic and visco-elastic. Blood viscosity depends upon macroscopic factors, such as erythrocyte aggregation and deformability. Hyperviscosity is observed in cases of increased haematocrit (polycythaemia and relative polycythaemia), increased serum proteins and changes in protein balance (e.g. rise in fibrinogen and immunoglobulins, fall in albumin) as seen in inflammation and dysglobulinaemia, drop in temperature (hypothermia), increased erythrocyte aggregation (shock, fat embolism) or imparied deformability due to various acquired or inherited disorders of red cell membrane or cytoplasma (e.g. sickle cell anaemia, renal failure, hyperlipoproteinaemias, thrombosis, diabetes). The various factors may be combined, as in diabetes. Conversely, hypoviscosity may result from decreased haematocrite, fall in blood proteins and fibrinogen, or hyperthermia. Hyperviscosity can be corrected by acting on its various constituents. Treatments include haemodilution, plasmapheresis, anti-aggregants and drugs improving red cell deformability.
Similar articles
-
[Blood hyperviscosity syndromes. Classification and physiopathological understanding. Therapeutic deductions].Ann Med Interne (Paris). 1983;134(5):395-410. Ann Med Interne (Paris). 1983. PMID: 6360007 Review. French.
-
Introduction to hemorheology: theoretical aspects and hyperviscosity syndromes.Int Angiol. 1987 Apr-Jun;6(2):119-32. Int Angiol. 1987. PMID: 3323349 Review.
-
[Hemorrheology in clinical practice. Applications in an in vitro study of troxerutin].Rev Fr Gynecol Obstet. 1991 Feb 25;86(2 Pt 2):200-5. Rev Fr Gynecol Obstet. 1991. PMID: 1767174 French.
-
Blood rheology in vitro and in vivo.Baillieres Clin Haematol. 1987 Sep;1(3):597-636. doi: 10.1016/s0950-3536(87)80018-5. Baillieres Clin Haematol. 1987. PMID: 3327559 Review.
-
Red blood cell microrheology (clinical and pharmacological applications).Ric Clin Lab. 1983;13 Suppl 3:53-70. Ric Clin Lab. 1983. PMID: 6369496 Review.
Cited by
-
Prevalence of anemia and risk of adverse bleeding effect of drugs: implication for therapy.Anemia. 2012;2012:795439. doi: 10.1155/2012/795439. Epub 2012 Feb 28. Anemia. 2012. PMID: 22506109 Free PMC article.
-
CARDIOVASCULAR RISK ASSESSMENT AND SUPPORT TECHNIQUES: Whole blood viscosity assessment issues I: Extrapolation chart and reference values.N Am J Med Sci. 2010 Apr;2(4):165-9. doi: 10.4297/najms.2010.2165. N Am J Med Sci. 2010. PMID: 22624134 Free PMC article.
-
Whole blood viscosity assessment issues IV: Prevalence in acute phase inflammation.N Am J Med Sci. 2010 Aug;2(8):353-8. doi: 10.4297/najms.2010.2353. N Am J Med Sci. 2010. PMID: 22737672 Free PMC article.
-
Blood Viscosity Changes in Diabetes Mellitus: A 20-Year Bibliometric Review and Future Directions.Cureus. 2024 Jul 10;16(7):e64211. doi: 10.7759/cureus.64211. eCollection 2024 Jul. Cureus. 2024. PMID: 39130872 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical